Cargando…

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

Detalles Bibliográficos
Autores principales: Lau, Jillian SY., Rasmussen, Thomas A., Lewin, Sharon R., Ehm, Adam, Martinez, Cipriano, Burnett, Craig, McMahon, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868108/
https://www.ncbi.nlm.nih.gov/pubmed/33585037
http://dx.doi.org/10.1016/j.jve.2021.100032
_version_ 1783648399631843328
author Lau, Jillian SY.
Rasmussen, Thomas A.
Lewin, Sharon R.
Ehm, Adam
Martinez, Cipriano
Burnett, Craig
McMahon, James H.
author_facet Lau, Jillian SY.
Rasmussen, Thomas A.
Lewin, Sharon R.
Ehm, Adam
Martinez, Cipriano
Burnett, Craig
McMahon, James H.
author_sort Lau, Jillian SY.
collection PubMed
description
format Online
Article
Text
id pubmed-7868108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78681082021-02-09 Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings Lau, Jillian SY. Rasmussen, Thomas A. Lewin, Sharon R. Ehm, Adam Martinez, Cipriano Burnett, Craig McMahon, James H. J Virus Erad Letter to the Editor Elsevier 2021-02-07 /pmc/articles/PMC7868108/ /pubmed/33585037 http://dx.doi.org/10.1016/j.jve.2021.100032 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Lau, Jillian SY.
Rasmussen, Thomas A.
Lewin, Sharon R.
Ehm, Adam
Martinez, Cipriano
Burnett, Craig
McMahon, James H.
Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
title Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
title_full Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
title_fullStr Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
title_full_unstemmed Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
title_short Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
title_sort interrupting antiretroviral therapy in hiv cure trials during covid-19: adaptation to low transmission settings
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868108/
https://www.ncbi.nlm.nih.gov/pubmed/33585037
http://dx.doi.org/10.1016/j.jve.2021.100032
work_keys_str_mv AT laujilliansy interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings
AT rasmussenthomasa interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings
AT lewinsharonr interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings
AT ehmadam interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings
AT martinezcipriano interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings
AT burnettcraig interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings
AT mcmahonjamesh interruptingantiretroviraltherapyinhivcuretrialsduringcovid19adaptationtolowtransmissionsettings